Post BCG lymphadenitis in vaccinated infants in Yazd, Iran

Iranian Journal of Pediatrics

Volumn 18, Issue 4, 2008, Pages 351-356

  Behjati, Mostafa ^a,b   Ayatollahi, Jamshid ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Afshar Hospital   (Iran)

Author keywords

BCG; Immunization; Infants; Lymphadenitis; Tuberculosis; Vaccination

Indexed keywords

BCG VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; TRIPLE VACCINE;

ARTICLE; AXILLARY LYMPH NODE; BCG VACCINATION; BRACHIAL PLEXUS; FEMALE; FISTULA; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; IRAN; LYMPHADENITIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLIOMYELITIS; REMISSION; SINGLE DRUG DOSE; SUPPURATION; TUBERCULOSIS;

EID: 63249087432     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Styblo K, Meiger J. Impact of BCG Vaccination program in children and young adults on the tuberculosis problem. Tuber Lung Dis J. 1976;57(1):17-43.
2. Lugosi L. Theoretical and methodological aspects of BCG Vaccine from the discovery of Calmette and Guerin to molecular biology. A review. Tuber Lung Dis J. 1992; 73(5):252-61.
3. Bonmon MJ. BCG and Tuberculosis, Arch Dis Child. 1999;80(1):80-3.
4. Kaur S, Faridi M M A, Agarwal KN, BCG Vaccination reaction in low birth weight infants, Indian J Med Res. New Delhi. 2002;116:64-69.
5. Goraya JS, Virdi VS, Bacilli calmette-Guerin lymphadenitis. Postgraduate Med J London. 2002;78(920):327-9.
6. Milstien JB, Gibson JJ. Quality control of BCG Vaccine by WHO: a review of factors that may influence Vaccine effectiveness and safety. Bull WHO. 1990;68(1):93-108.
7. Barouni AS, Augusto C, Queiroz MVNP, et al. BCG Lymphanopathy detected in a BCG vaccinated infant. Braz J Med Biol Res. 2004;37(5):697-700.
8. Starke JR, Munoz F. Tuberculosis, BCG Vaccination. In: Kliegma RM, Behrman RE, Jenson HB, (eds). Nelson Textbook of Pediatric. 17 ed. Philadelphia; Saunders. 2004; Pp:958-72.
9. Langley J, Ellis E, Deeks S, National Advisory Committee on Immunization; Health Canada First Nations; Inuit Health Branch. Statement on Bacille Calmette Guérin (BCG) vaccine. Can Commun Dis Rep. 2004;30:ACS-5.
10. Golebiowska M, Andrzejewska E, Stryjewska I, et al. Adverse events following BCG vaccination in infants and children up to 36 months of age. Przegl Epidemiol. 2008;62(1):71-5.
11. Szczuka I. Adverse event after BCG Vaccination in Poland in the years 1994-1997. Pneumonol Alergol Pol. 1999;67(5-6): 208-16.
12. Baek HC, Chang JY, Moon SJ, Oh SH. Lymphadenitis following interadermal BCG vaccination. Korean J Pediatr. 2006; 49(1):46-50
13. Award R. BCG Vaccine and post BCG Complications among infant in Gaza strip1999. East Mediter Health J. 2001; 7(1-2): 221-220.
14. Evaluation of BCG vaccination programmes. Weekly Epidemiological Records. 1982;57(16):121-123
15. Tidjani O, Amedome A. The protective effect of BCG vaccination of the newborn against children tuberculosis in an African community. Tubercle. 1986;67(4):269-81.
16. Sirinavin S, Chotpitayasunondh T, Suwanjutha S, et al. Protective efficacy of neonatal Bacillus Calmette-Guerin vaccination against tuberclosis. Pediatr Infect Dis J. 1995;10(5):359-65.
17. Praveen KV, Smikle MF, Prabhakar P. Outbreak of BCG vaccine associated lymphadenitis and abscess in Jamaica. Pediatr Infect Dis J. 1990;9(12):890-3.
18. Jeena PM, Chhagam MK, Topley J, et al. Safety of the intradernal BCG vaccine in neonate in Durban, South Africa. Bull WHO. 2001;79(4):337-43.
19. Singla A, Singh S, Goraya JS, etal. The natural course of BCG lymphadenitis. Pediatr Infect Dis J. 2002;21(5):446-8.
20. Seyfhashemi M, Hemati A, Mazaheri M, et al. Complications of BCG vaccination in children. Iran J Pediatr. 2005;15(3):210-4. (Article in Farsi)
21. Saba MS, Farshchian M, BCG adenitis Hakim Res J. 1999;2(2):84-7. (Article in Farsi)
22. Stone MM, Vannier AM, Storch, SK, et al. Brief report, Meningitis due to iatrogenic BCG infection on two imunocompromised children. N Eng J Med. 1995;333(9):561-3.
23. Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to BCG Vaccination with Multipuncture method. Tuber Lung Dis. 1996;77(3):769-73.
24. Lanchriet C, Levy-Bruhl D, Bingono E. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Int J Epidemiol. 1995;24(5):1042-9.
25. Ray CS, Pringle D, Legg W, et al. Lymphadenitis associated with BCG vaccine: A report of an outbreak in Harare Zimbabwe. Cent Afr J Med. 1988;34(12): 281-6.
26. Nazir Z, Qozi SH. Bacillus Calmett-Guerin (BGC) lymphadenitis- Changing Trends and management. J Ayub Med Coll Abbottabab. 2005;17(4):16-8.
27. Bareto Ml, Pereira SM, Fereiera AM, BCG vaccine: efficacy and indication for vaccination and revaccination. J pediatr (RioJ). 2006; 82 (3 supple):S45-54.
28. Masjedi MR. Guideline for the fight against tuberculosis, Tuberculosis Research Center of Iran, Tehran, Shahid Beheshti Univercity of Medical Sciences, 1996; P: 43 (Book in Farsi).
29. WHO Tuberculosis research office suppurative lymphadenitis following intradermal BCG vaccination of preschool children. Bull WHO. 1995;12(1-2):143-67.
30. Bolger T, O'Connell M, Menon A, et al. Complications associated with the bacille Calmette Guérin vaccination in Ireland. Arch Dis Child. 2006;91(7):594-7.